HomeNewsBusinessAnnouncementsGlenmark Pharma receives ANDA approval for Nystatin and Triamcinolone Acetonide Ointment USP

Glenmark Pharma receives ANDA approval for Nystatin and Triamcinolone Acetonide Ointment USP

Glenmark Pharmaceuticals Inc. USA has been granted final approval by the USFDA for Nystatin and Trimcinolone Acetonide Ointment USP, 100000 units/1 mg gram.

June 24, 2016 / 08:53 IST
Story continues below Advertisement

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated June 24, 2016 titled "Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/1 mg per gram".Source : BSE

Read all announcements in Glenmark

first published: Jun 24, 2016 08:53 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!